检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]山东省临沂市沂水中心医院药剂科,山东沂水276400 [2]山东省临沂市沂水中心医院神经外科,山东沂水276400
出 处:《中华肿瘤防治杂志》2012年第14期1091-1093,共3页Chinese Journal of Cancer Prevention and Treatment
摘 要:目的:观察球囊法32P内放疗同步替莫唑胺化疗对脑胶质瘤的临床疗效。方法:选取脑胶质瘤患者105例作为研究对象,随机分为两组,A组(52例)为球囊法32P内放疗组,B组(53例)为行球囊法32 P内放疗同步替莫唑胺化疗组。比较两组肿瘤体积缓解率及1、2和3年生存率,分析其疗效;比较两组治疗后KPS评分,分析其治疗不良反应。结果:A组患者治疗后完全缓解、部分缓解、好转、稳定和进展分别为6、15、9、14和8例,B组分别为14、23、8、4和4例;1、2和3年生存率分别为78.8%、57.7%、40.4%和92.4%、77.4%、60.4%;6个月、1和3年KPS评分分别为75.89±9.23、71.97±10.73、64.31±10.11和85.22±9.40、83.96±10.33、81.97±11.01,经统计学分析组间差异均有统计学意义,P<0.05。结论:球囊法32P内放疗同步替莫唑胺化疗治疗脑胶质瘤优于单纯球囊法32P内放疗。OBJECTIVE: To study clinical efficacy of balloon 32 p internal radiotherapy with Mo temozolomide chemotherapy for brain glioma, and find out the more effective protocol for brain glioma. METHODS: Total 105 cases were randomly selected and divided into 2 groups. Group A (52 cases) was Balloon 32p Internal Radiotherapy only; Group B (53 cases) was Balloon method 32p internal radiotherapy and Mo temozolomide chemotherapy. Tumor volume response rate and 1,2,3 year survival rate of two groups were analyzed and KPS score was compared. The treatment side effects was analyzed. RESULTS: After treatment, complete remission, partial remission, better stability and progress in groups A were 6 cases,15 cases,9 cases,14 cases,8 cases, and in group B those were 14 cases,23 cases,8 cases,4 cases,4 cases;l, 2,3 year survival rates in group A and B were 78.8%,57.7%,40.4%and 92.4%,77.4%,60.4%; KPS score of 0.5,1, 3 years were 75.89±9.23,71.97±10.73,64.31±10. 11 and 85.22±9.40,83.96±10.33,81.97±11.01, There was a significant differences between the groups (P〈0.05). CONCLUSION: Balloon method 32p internal radiotherapy for Mo temozolomide chemotherapy for glioma is better than simple balloon 32P internal radiotherapy.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.63